{"ticker": {"uuid": "40a5e333-7a58-4da5-9a4c-4e554f98f8c2", "symbol": "PRTC", "name": "PureTech Health plc", "exchange": "LSE", "country": "GB", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "REG - PureTech Health PLC - PDMR Notification RSU Vesting", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxPQTBGMnlzS0Y3bG9UMHBtMHBFNENibDY4VG42OUQ1bE44RzlvdGlzY2hZRklfWmVtd2xOMzRVVzdvMksyd1BDZEJmaEVJMnI0eXFJUEphbWtZX1RuZVRWTUxyTU1LaUVLNnlVNVY0c1hDb2NSandpTXZwSVBkY2xfSWRyYnMwRElJWW9YektCRnBpV0E4bFpiQ3hCclpuTDN6NHpPYTFMOUE5ZHhPTVdCajFDZ2pXNjFtc1NHNUk3a2FVRjloSWlGSw?oc=5", "source_name": "TradingView", "published_at": "2026-07-17T16:00:00+00:00", "published_display": "17 Jul 2026 16:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PureTech Subsidiary Celea Begins Phase 3 IPF Study Comparing Deupirfenidone With Standard Therapy (PRTC)", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxObFlDalZjYlRoWklDWDNmUEkxVEdhQWE3bXRqVE80UDZ3UmFvYjFReXVJblUwN3l4X25FNGxkdGtTZlF0Z1lmZkpNZ0UybmxmSmJxWEdlbGhXY3RDT3NHamY5amgtY0NQdnJTcHc0QTlrNHFXV0J1cG5mTkxBTVc0clNHM01JTWdwal8zc1l1OUo?oc=5", "source_name": "Market source", "published_at": "2026-07-13T07:16:27+00:00", "published_display": "13 Jul 2026 07:16", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "REG - PureTech Health PLC - PRTC: Celea Doses 1st Patient in Phase 3 IPF Trial", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4wFBVV95cUxNWVZjM3dUTi1VVy1IRl9WWTQ1dVRoSlF0eC1QVHlpNWloT2lKX0xVa0NvRlV0T0pDT1NLYjYyaTJXUkJsbGZqMjFxZlByLUlCYzYxVmJLeVdCZG0wS1JIZS1OYXdzQ1g4VExGRC1VTDdqQ241NDBKbVJLeXRtN1pFM2xwSU5nb2l6QzRJZmU5SWpCb0ljRHVEb040OUd2LURuSVJvUy01U3A5ZlFQZV9DY3UwQ19xb296TmItUDQyZmRXMU50TUFfQnoteEhnWkkzSjVxajFsY29DS1Z3TWo1VGlVWQ?oc=5", "source_name": "TradingView", "published_at": "2026-07-13T06:00:00+00:00", "published_display": "13 Jul 2026 06:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DIRECTOR DEALINGS: PureTech Health directors buy GBP176,000 in shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxQUlRFV1VmWi00RFl5Nlk1ZEVxMkJCaDFkLVVKRTdhYW5leHQ1QWJpR2xnUzlwcUMzd2M4YWRRNERRTy14alBWdFJxVExiSmJBWThELW9ZbVhBNGwxa1ViY3FBNDgtbmh3eWc5QTltY2VDaHloUElBSGxoQThpaW9lWTdrUURwZHNDZnJHTTVBM0dmbHhWRjdkWkI5WTF3YTdELWRqMkx3enh6MG12amtTOVFqbnVVZw?oc=5", "source_name": "London South East", "published_at": "2026-07-09T15:37:00+00:00", "published_display": "09 Jul 2026 15:37", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "REG - PureTech Health PLC - Director/PDMR Shareholding", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxNLTVjMUJkVFV4OVpwU2dFOFZTOXlIVGJQdW1YZzIyUDdFcTk1bFhQX2Nzd1R0c2ExY1JtRE9CRnZqUHRvMkZ2QlNpUUczNWJsNFE3Z1RmZGJUc25ha054RUttdnF6YWIyOUpzMHRCaTZFVjlOTjhSOUE4RzdrMlR4R055RklSblpQU0ZWVUROZXZOYWlDUmNPQjdUVmZWVmlPTXFCMjNrU3hhQUtpSjFodlFiekNBMXV4ZHF4d1Rpekt3WmxX?oc=5", "source_name": "TradingView", "published_at": "2026-07-09T06:00:00+00:00", "published_display": "09 Jul 2026 06:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PureTech Health (PRTC) Edges Higher as Shares Hold Above Key Support - Extension Target", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxOMzAtYXZjbndSVFFuZlVFemxMT3ZGLWE0Zm5FZjV2Zzl1LUtSdTlhZEs5Y0hmNjUzMVNWaGhfV0QwaGwtZlhyNVJ0RE5SSGhLdEtkaVlGREx6NTFiUW1MS1RBLUgteWs5cjluYTlfLURyZ3dBMzdteTR1WGV3MzlaRUo1V0RJUjNNWkhWZ3RTQmFWbXYzazB0cURWQ2tmQkxKT1pZVl9Hb0IwM3lk?oc=5", "source_name": "dars.gov.et", "published_at": "2026-07-08T21:31:16+00:00", "published_display": "08 Jul 2026 21:31", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PRTC Stock Price and Chart \u2014 LSE:PRTC", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWEFVX3lxTE1wNjhFY1J1Ynd5alFPamVucGU2c0prYVZSM0V3alNKVHk4NjNEY3lkbzJQSVoxT0dGOUFIbzhjWlNhZnJWU2tYS1pFdjFyWU8tRGxjT21iT2c?oc=5", "source_name": "TradingView", "published_at": "2026-07-07T07:00:00+00:00", "published_display": "07 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "REG - PureTech Health PLC - PRTC Launches Celea: $180M & Asset Transfer", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxNMFNjTFBsRmRzVXdxMGZ0YTRrVVlsVU4wbHFjNjIxTWJybDlvVkZackZzTWtyd2p4NFRUQ2ZHWWpTUDZwRG01NHU4NDVQem9IZjFJRXhDdWF6UVlMSUpDeWhKbnJwc1lDQUxNcURlSjBPaTFhMjQ3UE9XYXhWalhUODNZRzB2YlljY3BYbDl4RVFLZnlqYnRvWURmRVNqZ01LWFphb3JYVnYzcTAtTTNYY0MtNFBvOHJPZ1RZVXc2SDEyWkdGVVRac1ZzZDRwT04zQnFwdlVR?oc=5", "source_name": "TradingView", "published_at": "2026-07-02T06:00:00+00:00", "published_display": "02 Jul 2026 06:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PureTech Health PLC Actuals & Estimates (LSE:PRTC)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggFBVV95cUxNdEhxZTVHYjVsZGZ2bDFsZ0h0S1ZYeXZ0Z3BNVXMyUnZDaGlxTXdqWU1QanFlTnVjazhfM05NMEFJbFY1Z19IZjdhZVE1TTluTjNoRG1QNnFkODBKLVVRc0hxOTRsQ3NtOG82ZFgxYkNFTVowN3U3RThfSlVEZHJXeEx3?oc=5", "source_name": "TradingView", "published_at": "2026-06-26T20:06:16+00:00", "published_display": "26 Jun 2026 20:06", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PureTech Health PLC (PRTC) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "", "url": "https://news.google.com/rss/articles/CBMicEFVX3lxTFB0YVp4cHVqZFc3OGFfUVNOUXZoTlBGTndSZmRSQ2NmcDNWSjY0MHlnX0V0VmZYVjNYVFVUM1RiOV9TRmtJTHFxbF9uNWc4RmRuTlIzcnZqNTNrYVJfR0VIZmQ4RXAyUmFLY0JRMzFZdFQ?oc=5", "source_name": "TradingKey", "published_at": "2026-06-18T12:53:26+00:00", "published_display": "18 Jun 2026 12:53", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PureTech Health plc (PRTC) Q4 2024 Earnings: EPS Misses Estimates as Clinical-Stage Biotech Advances Pipeline - Tangible Book Value", "summary": "", "url": "https://news.google.com/rss/articles/CBMi7wFBVV95cUxPR1RvZnZpaVZUYndXb2RfV3lTbkstSGx2WG5wNnZwVGhTem5IaHFsMEh0OXpsQTc5OHc1Zmd2ZF9nUnpYTHdMa2ZNNVh4dm5ZNGw3RGRZY28zWGFPcVhFZXBRcm5ZMEsyOUZhQTN3cmY2ZjBDRVlINlhUOHkxbFl6RWhKSmhfalVPWUxUT0N3emlmaFJFUWZxbTB5QXowLV9UOVdyWVdzRGNSdTRaSjVWWGZnekRXVEx4Yi1raDNuOXA5VENrNkRUX0gtUHM2aGxvSlhoZ2NnVGVOdmNubGxDTkxadUQ4WURpY3ctVmEwcw?oc=5", "source_name": "B\u00f6l\u00fcm Sonu Canavar\u0131", "published_at": "2026-06-07T07:00:00+00:00", "published_display": "07 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 15, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PureTech Health Plc (LSE:PRTC) Share Price, History, & News", "summary": "", "url": "https://news.google.com/rss/articles/CBMiW0FVX3lxTE1ONVQ3SmlhRmFfbUJ6MkRlcUhtRVFuSlc4a3gxNUlpQVhYYXRJMUxpVlpGRE9EX0NPM3QydmoxdENtWDhVdDdHNTZTdi1CSC00ZDdMWWVRSmwwdW8?oc=5", "source_name": "The Twelfth Magpie", "published_at": "2026-05-13T06:08:39+00:00", "published_display": "13 May 2026 06:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PureTech Health plc (PRTC) Stock Analysis: Navigating the Biotech Landscape with Clinical Innovations", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4wFBVV95cUxPNEZLRGtpYlM3LWpOdmdTWDc3NkRrbHh5TmwybjYzQS1LRS1Kc2FxQ0Qxd1NvcHJwNzBCUG1waUpuczk1OWZ0NldoOXljXzJ0ZHhiREh1dnI3QXEtNWg1ZVB2alc3Mkc5VlNxN3JNU1VhX19Ockh3Wm9ZTlo1M0JsUFZUUVpXSFB3UUhULXNPVVNEdHBtdERzblpTQ0lTeVBxeW1jUkNhd0ppOHJYUkJxVjNOZHhnbWRKMTU0bWhlZ1Fyc1A2NWZxWllGWHA1anNnaEViRWhNdGxqS2RyaHZHWjFFcw?oc=5", "source_name": "DirectorsTalk Interviews", "published_at": "2026-05-08T23:43:20+00:00", "published_display": "08 May 2026 23:43", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PureTech Health shares boosted as investee Seaport Therapeutics prices Nasdaq IPO", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6gFBVV95cUxNb0lqenhJbldNX2pKVElBX2lWMkpnb2tqVC1qeUVlQlZpRm82TVR4UGRXem51ZTJZMlVVTUtLX1FnYlAwYy1LLXBGVzNYMEdnSTJaSy1YeXZTSHp4SzVPMHNHVW4xUVZWTl9PYS1nYlV4d1F0SHVwNXdMMnJCc19vOE9kNHZHUmowNEtBOTdCQUVVZHJnZXhicTFwQlM2ZG44QmhBN3Bma2tCamhKMmN5bnhPaUpOa2NVVl9DNnJIdDJDVEV6U0tOMkoyY2RvWURFeHktdDBwVzNMM3lrZFFpbGtIcmdTWmhEcUE?oc=5", "source_name": "Proactive Investors", "published_at": "2026-05-01T07:00:00+00:00", "published_display": "01 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PureTech Announces Annual Results for Year Ended December 31, 2025", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxQR1h3TEtial9TTUhqVVVINXZwWnlwaWpDc2R4cXZuM0ZyQ2hNMXNNUVFMYmZ3cVQ5bU8yWC10dklrSXdQcFdWTDMtekJsdTg4Z3ZJMUxMeU5ESmVBRFFrazUzbFJOVGd4d3FwMFVMTzVCR05uc3F6dGt4eDlaVE5Da0RoZjdPY0xoSEFoUWhxU2pkQlRORGJmU2diVUZmUmlzVDY1U3JsUlY?oc=5", "source_name": "BioSpace", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PureTech Health to delist ADSs from Nasdaq, focus on LSE", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQTG5sNXpiV3JZTVJsM0VjcGw2UGVqcmhNX3l3MHdLOVdhMVNXNUdVVmoxRFBwcGE2V0tvLUloY0dZM1RNcElJM0JsM0RzQ3pCYlBvY3MtRVlXVGFlQUlGbGlFVFlRNEszOG5VX3ZpWVM2aV9ObzJxYVUtU0pFSlBCenBSS0U5RDNJd2s2WnBIbUdONzJoc0VKaEhoYUJfVTlWZlNPdWxSVVVRazRSZk1CVmF3?oc=5", "source_name": "Investing.com", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PureTech Announces Intention to Voluntarily Delist American Depositary Shares from Nasdaq and Concentrate Trading on the London Stock Exchange", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgJBVV95cUxQbTNBNXNJSGN0THFMd0ROelZhMnlMTHIxVXQ1Yk5IWlJla3B2TVFyMnI2bGpYbG9hXzVBTGxWZ1p0M1ZaM0lZVkpPeGUzb0F1ekRsd0ZETENMWnJ1ckh4SFdRa3JTaFBFbk5pdFY0NmRGNzQ5VkVZeDR5eHZoTXJCY3d1d0xSQkw0eFgxZ0JCWlRjNkRfdXZRZ1Q1eTNjMVgyeG1NZmRHVy1wb1FCa0lQM0tsaV9wdHk4TVpNM3gyUW1zQkhqRGQ1Z1lGd0tqOW94NFVYczVoaDJqTEpaaDE5SVVjaHVRX0tjbkotZEY4dFdzbjJHZVRIVWl0VC1LUjNScERiVC1uenhRYVBGRHhDYmVYbmRNUWRqOE5nRDdmQXNsM2pqUGc?oc=5", "source_name": "Business Wire", "published_at": "2026-04-28T07:00:00+00:00", "published_display": "28 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PureTech Announces Publication of Phase 2b ELEVATE IPF Trial Results in The American Journal of Respiratory and Critical Care Medicine", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwJBVV95cUxNUjgwaVJMQ2xpSmphOUN4SU9XdFp5RkJfSFZVUzVvVTZ1VGRGVGVsS3ZHblBqMW9PS1NSS1pDbnFGY3MyUWZrd3ZDbU12cnZ6bGFvZUlyN2JTY3BkME5IYTF3c0tZQ1FrNmJDck53SnBQZzNfM1ptSi1GZDZHMGxPTktmSzdPTXNGcXpTVEpEVHRSLU9kVHk3cEotRzBHcWw3VnRFazdzVm5acldQNkFsdTNFTXFRb0tWZjRId0dKV0VlTnFHVy1jZHlSR1VvSEJZOUdmdEhjejZHOHlQWmF2Z3M1SGMyd0dBejNISkp3VWQ3ZGlPaWlNVC1FUks0RVdtNXdEMWFLTnpTWHF6dUVrVmtLcnBkNk9BNlE0?oc=5", "source_name": "Business Wire", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is PureTech Health in FTSE AIM 100?", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxQZy1BY3Z5cXRRWDF1RGhMRjhoVjg3SEFBVjRfYnFnZ3g4QnhEdkhDVnJvcnRGUVJBTEFHOGRhRHhsTl9QVnJwU0xCYVBkVDRvb1FpbWhWSDNVaTBNSXZ0ZldNRGxpZXloR3dXaXl0S2g0cFg1ZmQxRG9mX0hiSS1aTjh3R040bEk?oc=5", "source_name": "Kalkine Media", "published_at": "2026-03-31T07:00:00+00:00", "published_display": "31 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Recent uptick might appease PureTech Health plc (LON:PRTC) institutional owners after losing 12% over the past year", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-09-23T07:00:00+00:00", "published_display": "23 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SUNDAY NEWSPAPER SHARE TIPS: PureTech Health, Centamin, Ibstock and JD Wetherspoon", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "This is Money", "published_at": "2016-07-10T07:00:00+00:00", "published_display": "10 Jul 2016 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PureTech\u2019s long view on biopharma", "summary": "", "url": "https://news.google.com/rss/articles/CBMi9gFBVV95cUxQNTRrMzdldktYeFlpR0piLWkxb1BoRXd1QlJ1em15V2oxaWVIZloyaDBtcHB1SXREeDNHUTBvYkhWTHpzWFcwNHE2R2V5SkIzOUwzMXJvdmNZMmhFVDBrVkJSZkJUYUVWNDV6MDZ1dHlza0F6cXNiVmdZclFKYmZER0wtdXZESUxPTUVYVnA2a1FjcnM3aEV5S0xnWTE4eEljQUE1UHl5RDB2eWk1Y3ZwS0l3RlRDUy1GSE90cnlNUTNEOVZ6LWk5ZEpVR2NvRXpIR01VeEJ0NWVVLWM0ZzUwTWVpYmNlUnZmSkQ4cXk0VUxSRDBFMHc?oc=5", "source_name": "The Boston Globe", "published_at": "2015-08-26T07:00:00+00:00", "published_display": "26 Aug 2015 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "REG - PureTech Health PLC - PDMR Notification RSU Vesting", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxPQTBGMnlzS0Y3bG9UMHBtMHBFNENibDY4VG42OUQ1bE44RzlvdGlzY2hZRklfWmVtd2xOMzRVVzdvMksyd1BDZEJmaEVJMnI0eXFJUEphbWtZX1RuZVRWTUxyTU1LaUVLNnlVNVY0c1hDb2NSandpTXZwSVBkY2xfSWRyYnMwRElJWW9YektCRnBpV0E4bFpiQ3hCclpuTDN6NHpPYTFMOUE5ZHhPTVdCajFDZ2pXNjFtc1NHNUk3a2FVRjloSWlGSw?oc=5", "source_name": "TradingView", "published_at": "2026-07-17T16:00:00+00:00", "published_display": "17 Jul 2026 16:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PureTech Subsidiary Celea Begins Phase 3 IPF Study Comparing Deupirfenidone With Standard Therapy (PRTC)", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxObFlDalZjYlRoWklDWDNmUEkxVEdhQWE3bXRqVE80UDZ3UmFvYjFReXVJblUwN3l4X25FNGxkdGtTZlF0Z1lmZkpNZ0UybmxmSmJxWEdlbGhXY3RDT3NHamY5amgtY0NQdnJTcHc0QTlrNHFXV0J1cG5mTkxBTVc0clNHM01JTWdwal8zc1l1OUo?oc=5", "source_name": "Market source", "published_at": "2026-07-13T07:16:27+00:00", "published_display": "13 Jul 2026 07:16", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "REG - PureTech Health PLC - PRTC: Celea Doses 1st Patient in Phase 3 IPF Trial", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4wFBVV95cUxNWVZjM3dUTi1VVy1IRl9WWTQ1dVRoSlF0eC1QVHlpNWloT2lKX0xVa0NvRlV0T0pDT1NLYjYyaTJXUkJsbGZqMjFxZlByLUlCYzYxVmJLeVdCZG0wS1JIZS1OYXdzQ1g4VExGRC1VTDdqQ241NDBKbVJLeXRtN1pFM2xwSU5nb2l6QzRJZmU5SWpCb0ljRHVEb040OUd2LURuSVJvUy01U3A5ZlFQZV9DY3UwQ19xb296TmItUDQyZmRXMU50TUFfQnoteEhnWkkzSjVxajFsY29DS1Z3TWo1VGlVWQ?oc=5", "source_name": "TradingView", "published_at": "2026-07-13T06:00:00+00:00", "published_display": "13 Jul 2026 06:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DIRECTOR DEALINGS: PureTech Health directors buy GBP176,000 in shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxQUlRFV1VmWi00RFl5Nlk1ZEVxMkJCaDFkLVVKRTdhYW5leHQ1QWJpR2xnUzlwcUMzd2M4YWRRNERRTy14alBWdFJxVExiSmJBWThELW9ZbVhBNGwxa1ViY3FBNDgtbmh3eWc5QTltY2VDaHloUElBSGxoQThpaW9lWTdrUURwZHNDZnJHTTVBM0dmbHhWRjdkWkI5WTF3YTdELWRqMkx3enh6MG12amtTOVFqbnVVZw?oc=5", "source_name": "London South East", "published_at": "2026-07-09T15:37:00+00:00", "published_display": "09 Jul 2026 15:37", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "REG - PureTech Health PLC - Director/PDMR Shareholding", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxNLTVjMUJkVFV4OVpwU2dFOFZTOXlIVGJQdW1YZzIyUDdFcTk1bFhQX2Nzd1R0c2ExY1JtRE9CRnZqUHRvMkZ2QlNpUUczNWJsNFE3Z1RmZGJUc25ha054RUttdnF6YWIyOUpzMHRCaTZFVjlOTjhSOUE4RzdrMlR4R055RklSblpQU0ZWVUROZXZOYWlDUmNPQjdUVmZWVmlPTXFCMjNrU3hhQUtpSjFodlFiekNBMXV4ZHF4d1Rpekt3WmxX?oc=5", "source_name": "TradingView", "published_at": "2026-07-09T06:00:00+00:00", "published_display": "09 Jul 2026 06:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PureTech Health (PRTC) Edges Higher as Shares Hold Above Key Support - Extension Target", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxOMzAtYXZjbndSVFFuZlVFemxMT3ZGLWE0Zm5FZjV2Zzl1LUtSdTlhZEs5Y0hmNjUzMVNWaGhfV0QwaGwtZlhyNVJ0RE5SSGhLdEtkaVlGREx6NTFiUW1MS1RBLUgteWs5cjluYTlfLURyZ3dBMzdteTR1WGV3MzlaRUo1V0RJUjNNWkhWZ3RTQmFWbXYzazB0cURWQ2tmQkxKT1pZVl9Hb0IwM3lk?oc=5", "source_name": "dars.gov.et", "published_at": "2026-07-08T21:31:16+00:00", "published_display": "08 Jul 2026 21:31", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PRTC Stock Price and Chart \u2014 LSE:PRTC", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWEFVX3lxTE1wNjhFY1J1Ynd5alFPamVucGU2c0prYVZSM0V3alNKVHk4NjNEY3lkbzJQSVoxT0dGOUFIbzhjWlNhZnJWU2tYS1pFdjFyWU8tRGxjT21iT2c?oc=5", "source_name": "TradingView", "published_at": "2026-07-07T07:00:00+00:00", "published_display": "07 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "REG - PureTech Health PLC - PRTC Launches Celea: $180M & Asset Transfer", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxNMFNjTFBsRmRzVXdxMGZ0YTRrVVlsVU4wbHFjNjIxTWJybDlvVkZackZzTWtyd2p4NFRUQ2ZHWWpTUDZwRG01NHU4NDVQem9IZjFJRXhDdWF6UVlMSUpDeWhKbnJwc1lDQUxNcURlSjBPaTFhMjQ3UE9XYXhWalhUODNZRzB2YlljY3BYbDl4RVFLZnlqYnRvWURmRVNqZ01LWFphb3JYVnYzcTAtTTNYY0MtNFBvOHJPZ1RZVXc2SDEyWkdGVVRac1ZzZDRwT04zQnFwdlVR?oc=5", "source_name": "TradingView", "published_at": "2026-07-02T06:00:00+00:00", "published_display": "02 Jul 2026 06:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PureTech Health PLC Actuals & Estimates (LSE:PRTC)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggFBVV95cUxNdEhxZTVHYjVsZGZ2bDFsZ0h0S1ZYeXZ0Z3BNVXMyUnZDaGlxTXdqWU1QanFlTnVjazhfM05NMEFJbFY1Z19IZjdhZVE1TTluTjNoRG1QNnFkODBKLVVRc0hxOTRsQ3NtOG82ZFgxYkNFTVowN3U3RThfSlVEZHJXeEx3?oc=5", "source_name": "TradingView", "published_at": "2026-06-26T20:06:16+00:00", "published_display": "26 Jun 2026 20:06", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PureTech Health PLC (PRTC) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "", "url": "https://news.google.com/rss/articles/CBMicEFVX3lxTFB0YVp4cHVqZFc3OGFfUVNOUXZoTlBGTndSZmRSQ2NmcDNWSjY0MHlnX0V0VmZYVjNYVFVUM1RiOV9TRmtJTHFxbF9uNWc4RmRuTlIzcnZqNTNrYVJfR0VIZmQ4RXAyUmFLY0JRMzFZdFQ?oc=5", "source_name": "TradingKey", "published_at": "2026-06-18T12:53:26+00:00", "published_display": "18 Jun 2026 12:53", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PureTech Health plc (PRTC) Q4 2024 Earnings: EPS Misses Estimates as Clinical-Stage Biotech Advances Pipeline - Tangible Book Value", "summary": "", "url": "https://news.google.com/rss/articles/CBMi7wFBVV95cUxPR1RvZnZpaVZUYndXb2RfV3lTbkstSGx2WG5wNnZwVGhTem5IaHFsMEh0OXpsQTc5OHc1Zmd2ZF9nUnpYTHdMa2ZNNVh4dm5ZNGw3RGRZY28zWGFPcVhFZXBRcm5ZMEsyOUZhQTN3cmY2ZjBDRVlINlhUOHkxbFl6RWhKSmhfalVPWUxUT0N3emlmaFJFUWZxbTB5QXowLV9UOVdyWVdzRGNSdTRaSjVWWGZnekRXVEx4Yi1raDNuOXA5VENrNkRUX0gtUHM2aGxvSlhoZ2NnVGVOdmNubGxDTkxadUQ4WURpY3ctVmEwcw?oc=5", "source_name": "B\u00f6l\u00fcm Sonu Canavar\u0131", "published_at": "2026-06-07T07:00:00+00:00", "published_display": "07 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 15, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PureTech Health Plc (LSE:PRTC) Share Price, History, & News", "summary": "", "url": "https://news.google.com/rss/articles/CBMiW0FVX3lxTE1ONVQ3SmlhRmFfbUJ6MkRlcUhtRVFuSlc4a3gxNUlpQVhYYXRJMUxpVlpGRE9EX0NPM3QydmoxdENtWDhVdDdHNTZTdi1CSC00ZDdMWWVRSmwwdW8?oc=5", "source_name": "The Twelfth Magpie", "published_at": "2026-05-13T06:08:39+00:00", "published_display": "13 May 2026 06:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PureTech Health plc (PRTC) Stock Analysis: Navigating the Biotech Landscape with Clinical Innovations", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4wFBVV95cUxPNEZLRGtpYlM3LWpOdmdTWDc3NkRrbHh5TmwybjYzQS1LRS1Kc2FxQ0Qxd1NvcHJwNzBCUG1waUpuczk1OWZ0NldoOXljXzJ0ZHhiREh1dnI3QXEtNWg1ZVB2alc3Mkc5VlNxN3JNU1VhX19Ockh3Wm9ZTlo1M0JsUFZUUVpXSFB3UUhULXNPVVNEdHBtdERzblpTQ0lTeVBxeW1jUkNhd0ppOHJYUkJxVjNOZHhnbWRKMTU0bWhlZ1Fyc1A2NWZxWllGWHA1anNnaEViRWhNdGxqS2RyaHZHWjFFcw?oc=5", "source_name": "DirectorsTalk Interviews", "published_at": "2026-05-08T23:43:20+00:00", "published_display": "08 May 2026 23:43", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PureTech Health shares boosted as investee Seaport Therapeutics prices Nasdaq IPO", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6gFBVV95cUxNb0lqenhJbldNX2pKVElBX2lWMkpnb2tqVC1qeUVlQlZpRm82TVR4UGRXem51ZTJZMlVVTUtLX1FnYlAwYy1LLXBGVzNYMEdnSTJaSy1YeXZTSHp4SzVPMHNHVW4xUVZWTl9PYS1nYlV4d1F0SHVwNXdMMnJCc19vOE9kNHZHUmowNEtBOTdCQUVVZHJnZXhicTFwQlM2ZG44QmhBN3Bma2tCamhKMmN5bnhPaUpOa2NVVl9DNnJIdDJDVEV6U0tOMkoyY2RvWURFeHktdDBwVzNMM3lrZFFpbGtIcmdTWmhEcUE?oc=5", "source_name": "Proactive Investors", "published_at": "2026-05-01T07:00:00+00:00", "published_display": "01 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PureTech Announces Annual Results for Year Ended December 31, 2025", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxQR1h3TEtial9TTUhqVVVINXZwWnlwaWpDc2R4cXZuM0ZyQ2hNMXNNUVFMYmZ3cVQ5bU8yWC10dklrSXdQcFdWTDMtekJsdTg4Z3ZJMUxMeU5ESmVBRFFrazUzbFJOVGd4d3FwMFVMTzVCR05uc3F6dGt4eDlaVE5Da0RoZjdPY0xoSEFoUWhxU2pkQlRORGJmU2diVUZmUmlzVDY1U3JsUlY?oc=5", "source_name": "BioSpace", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PureTech Health to delist ADSs from Nasdaq, focus on LSE", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQTG5sNXpiV3JZTVJsM0VjcGw2UGVqcmhNX3l3MHdLOVdhMVNXNUdVVmoxRFBwcGE2V0tvLUloY0dZM1RNcElJM0JsM0RzQ3pCYlBvY3MtRVlXVGFlQUlGbGlFVFlRNEszOG5VX3ZpWVM2aV9ObzJxYVUtU0pFSlBCenBSS0U5RDNJd2s2WnBIbUdONzJoc0VKaEhoYUJfVTlWZlNPdWxSVVVRazRSZk1CVmF3?oc=5", "source_name": "Investing.com", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PureTech Announces Intention to Voluntarily Delist American Depositary Shares from Nasdaq and Concentrate Trading on the London Stock Exchange", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgJBVV95cUxQbTNBNXNJSGN0THFMd0ROelZhMnlMTHIxVXQ1Yk5IWlJla3B2TVFyMnI2bGpYbG9hXzVBTGxWZ1p0M1ZaM0lZVkpPeGUzb0F1ekRsd0ZETENMWnJ1ckh4SFdRa3JTaFBFbk5pdFY0NmRGNzQ5VkVZeDR5eHZoTXJCY3d1d0xSQkw0eFgxZ0JCWlRjNkRfdXZRZ1Q1eTNjMVgyeG1NZmRHVy1wb1FCa0lQM0tsaV9wdHk4TVpNM3gyUW1zQkhqRGQ1Z1lGd0tqOW94NFVYczVoaDJqTEpaaDE5SVVjaHVRX0tjbkotZEY4dFdzbjJHZVRIVWl0VC1LUjNScERiVC1uenhRYVBGRHhDYmVYbmRNUWRqOE5nRDdmQXNsM2pqUGc?oc=5", "source_name": "Business Wire", "published_at": "2026-04-28T07:00:00+00:00", "published_display": "28 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PureTech Announces Publication of Phase 2b ELEVATE IPF Trial Results in The American Journal of Respiratory and Critical Care Medicine", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwJBVV95cUxNUjgwaVJMQ2xpSmphOUN4SU9XdFp5RkJfSFZVUzVvVTZ1VGRGVGVsS3ZHblBqMW9PS1NSS1pDbnFGY3MyUWZrd3ZDbU12cnZ6bGFvZUlyN2JTY3BkME5IYTF3c0tZQ1FrNmJDck53SnBQZzNfM1ptSi1GZDZHMGxPTktmSzdPTXNGcXpTVEpEVHRSLU9kVHk3cEotRzBHcWw3VnRFazdzVm5acldQNkFsdTNFTXFRb0tWZjRId0dKV0VlTnFHVy1jZHlSR1VvSEJZOUdmdEhjejZHOHlQWmF2Z3M1SGMyd0dBejNISkp3VWQ3ZGlPaWlNVC1FUks0RVdtNXdEMWFLTnpTWHF6dUVrVmtLcnBkNk9BNlE0?oc=5", "source_name": "Business Wire", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is PureTech Health in FTSE AIM 100?", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxQZy1BY3Z5cXRRWDF1RGhMRjhoVjg3SEFBVjRfYnFnZ3g4QnhEdkhDVnJvcnRGUVJBTEFHOGRhRHhsTl9QVnJwU0xCYVBkVDRvb1FpbWhWSDNVaTBNSXZ0ZldNRGxpZXloR3dXaXl0S2g0cFg1ZmQxRG9mX0hiSS1aTjh3R040bEk?oc=5", "source_name": "Kalkine Media", "published_at": "2026-03-31T07:00:00+00:00", "published_display": "31 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Recent uptick might appease PureTech Health plc (LON:PRTC) institutional owners after losing 12% over the past year", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-09-23T07:00:00+00:00", "published_display": "23 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SUNDAY NEWSPAPER SHARE TIPS: PureTech Health, Centamin, Ibstock and JD Wetherspoon", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "This is Money", "published_at": "2016-07-10T07:00:00+00:00", "published_display": "10 Jul 2016 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PureTech\u2019s long view on biopharma", "summary": "", "url": "https://news.google.com/rss/articles/CBMi9gFBVV95cUxQNTRrMzdldktYeFlpR0piLWkxb1BoRXd1QlJ1em15V2oxaWVIZloyaDBtcHB1SXREeDNHUTBvYkhWTHpzWFcwNHE2R2V5SkIzOUwzMXJvdmNZMmhFVDBrVkJSZkJUYUVWNDV6MDZ1dHlza0F6cXNiVmdZclFKYmZER0wtdXZESUxPTUVYVnA2a1FjcnM3aEV5S0xnWTE4eEljQUE1UHl5RDB2eWk1Y3ZwS0l3RlRDUy1GSE90cnlNUTNEOVZ6LWk5ZEpVR2NvRXpIR01VeEJ0NWVVLWM0ZzUwTWVpYmNlUnZmSkQ4cXk0VUxSRDBFMHc?oc=5", "source_name": "The Boston Globe", "published_at": "2015-08-26T07:00:00+00:00", "published_display": "26 Aug 2015 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 79, "total_relevant": 22, "sentiment_summary": {"positive": 2, "negative": 1, "neutral": 19, "score": 50, "total": 22, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 89, "events": [{"event": "general", "label": "Market update", "weight": 9.9, "count": 18}, {"event": "earnings", "label": "Earnings", "weight": 1.65, "count": 3}, {"event": "analyst", "label": "Analyst action", "weight": 0.55, "count": 1}], "positive_events": 2, "negative_events": 1}, "market_context": {"has_market_context": true, "latest_close": 120.0, "latest_week": "2026-07-10", "one_week_move": -0.2, "four_week_move": -8.5, "twelve_week_move": -9.4, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.197605, "market_dynamics_buy_signal": false, "relative_strength": -11.378047, "fair_value_gap": -23.5, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "undecided", "expectation_probability": 46.0336, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "-0.2% over one week, -8.5% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 51, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "TradingView", "count": 6}, {"label": "Business Wire", "count": 2}, {"label": "Market source", "count": 1}, {"label": "London South East", "count": 1}, {"label": "dars.gov.et", "count": 1}, {"label": "TradingKey", "count": 1}, {"label": "B\u00f6l\u00fcm Sonu Canavar\u0131", "count": 1}, {"label": "The Twelfth Magpie", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 22}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 18}, {"label": "Earnings", "count": 3}, {"label": "Analyst action", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "89/100 classification confidence."}, {"label": "Company focus", "value": "22", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-0.2% over one week, -8.5% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "REG - PureTech Health PLC - PDMR Notification RSU Vesting"}], "updated_at": "2026-07-17T16:53:08.908963+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}